A Study of BAX 888 in Male Adults With Severe Hemophilia A
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03370172 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 12, 2017
Last Update Posted : November 26, 2021
|
Sponsor:
Baxalta now part of Shire
Collaborators:
Baxalta Innovations GmbH, now part of Shire
Takeda Development Center Americas, Inc.
Information provided by (Responsible Party):
Takeda ( Baxalta now part of Shire )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | July 8, 2024 |
| Estimated Study Completion Date : | September 30, 2026 |